Deutsche Bank Ag\ Cabaletta Bio, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 22,361 shares of CABA stock, worth $51,206. This represents 0.0% of its overall portfolio holdings.

Number of Shares

22,361

Previous 14,018 59.52%

Holding current value

$51,206

Previous $104,000 0.96%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$3.94 - $8.24 $32,871 - $68,746	8,343 Added 59.52%	22,361 $105,000
Q2 2024 Aug 14, 2024	SELL	$7.22 - $18.82 $27,378 - $71,365	-3,792 Reduced 21.29%	14,018 $104,000
Q1 2024 May 15, 2024	BUY	$16.79 - $25.38 $8,075 - $12,207	481 Added 2.78%	17,810 $303,000
Q4 2023 Feb 14, 2024	SELL	$12.21 - $23.36 $46,471 - $88,908	-3,806 Reduced 18.01%	17,329 $393,000
Q3 2023 Nov 09, 2023	BUY	$11.84 - $18.65 $114,753 - $180,755	9,692 Added 84.7%	21,135 $321,000
Q2 2023 Aug 14, 2023	BUY	$7.65 - $13.95 $87,538 - $159,629	11,443 New	11,443 $147,000
Q4 2021 Feb 11, 2022	SELL	$3.36 - $14.64 $33 - $146	-10 Closed	0 $0
Q3 2021 Nov 04, 2021	BUY	$7.0 - $12.5 $7 - $12	1 Added 11.11%	10 $0
Q2 2021 Aug 11, 2021	SELL	$7.2 - $11.73 $60,271 - $98,191	-8,371 Reduced 99.89%	9 $0
Q1 2021 May 13, 2021	SELL	$10.39 - $14.53 $8,197 - $11,464	-789 Reduced 8.61%	8,380 $93,000
Q4 2020 Feb 16, 2021	BUY	$9.81 - $15.8 $25,466 - $41,016	2,596 Added 39.49%	9,169 $114,000
Q3 2020 Nov 12, 2020	BUY	$9.71 - $14.41 $6,117 - $9,078	630 Added 10.6%	6,573 $71,000
Q2 2020 Aug 13, 2020	BUY	$6.39 - $11.28 $24,869 - $43,901	3,892 Added 189.76%	5,943 $66,000
Q1 2020 May 14, 2020	SELL	$6.0 - $18.67 $792 - $2,464	-132 Reduced 6.05%	2,051 $15,000
Q4 2019 Feb 14, 2020	BUY	$7.88 - $17.71 $17,202 - $38,660	2,183 New	2,183 $30,000

Others Institutions Holding CABA

# of Institutions

126

Shares Held

47.9M

Call Options Held

202K

Put Options Held

110K

View Full List

About Cabaletta Bio, Inc.

Ticker CABA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,014,000
Market Cap $66.4M
Description
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...

More about CABA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account